Research and development status of PD-(L)1/TGF-β dual antibody
2022-09-05
On May 12, 2021, Hergrui PD-L1/TGFβ dual antibody SHR-1701 was declared as another clinical project. Up to now, SHR-1701 has entered clinical projects in 14, including 11 in China.
Read More >>
